Abstract: Seven pairwise comparisons of 5 different anti-epileptic drugs (AED) have been examined separately. Individual patient data (IPD) are available for a total of 14 randomised controlled trials (RCT) of these AED's in 3472 patients with epilepsy. As the number of trials included in any single comparison ranges from 2 (178 patients) to 5 (1265 patients), there is a need to improve the precision of the treatment effect estimates. A bayesian approach, incorporating IPD from all relevant trials is explored. The precision of a treatment effect estimate may be further improved by incorporating important prognostic factors using regression modelling. In our example from epilepsy, a high proportion of IPD are available for 5 pre-specified clinically important prognostic factors. Using regression modelling, we will investigate what impact these factors have on precision. The trade-off between including additional parameters in the model and improving the precision of the treatment effect estimate will also be discussed.
Can Indirect comparisons be improved using individual patient data?
Tags: Poster